These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 33202891)

  • 21. The Circulating Transcriptome as a Source of Biomarkers for Melanoma.
    Solé C; Tramonti D; Schramm M; Goicoechea I; Armesto M; Hernandez LI; Manterola L; Fernandez-Mercado M; Mujika K; Tuneu A; Jaka A; Tellaetxe M; Friedländer MR; Estivill X; Piazza P; Ortiz-Romero PL; Middleton MR; Lawrie CH
    Cancers (Basel); 2019 Jan; 11(1):. PubMed ID: 30634628
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Plasma BRAF Mutation Detection for the Diagnostic and Monitoring Trajectory of Patients with LDH-High Stage IV Melanoma.
    Tolmeijer SH; Koornstra RHT; de Groot JWB; Geerlings MJ; van Rens DH; Boers-Sonderen MJ; Schalken JA; Gerritsen WR; Ligtenberg MJL; Mehra N
    Cancers (Basel); 2021 Aug; 13(15):. PubMed ID: 34359813
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of microRNA-129-2-3p and microRNA-935 in plasma and brain tissue of human refractory epilepsy.
    Sun Y; Wang X; Wang Z; Zhang Y; Che N; Luo X; Tan Z; Sun X; Li X; Yang K; Wang G; Luan L; Liu Y; Zheng X; Wei M; Cheng H; Yin J
    Epilepsy Res; 2016 Nov; 127():276-283. PubMed ID: 27689807
    [TBL] [Abstract][Full Text] [Related]  

  • 24. miR-126-3p down-regulation contributes to dabrafenib acquired resistance in melanoma by up-regulating ADAM9 and VEGF-A.
    Caporali S; Amaro A; Levati L; Alvino E; Lacal PM; Mastroeni S; Ruffini F; Bonmassar L; Antonini Cappellini GC; Felli N; Carè A; Pfeffer U; D'Atri S
    J Exp Clin Cancer Res; 2019 Jun; 38(1):272. PubMed ID: 31227006
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Profiling of metastatic small intestine neuroendocrine tumors reveals characteristic miRNAs detectable in plasma.
    Bowden M; Zhou CW; Zhang S; Brais L; Rossi A; Naudin L; Thiagalingam A; Sicinska E; Kulke MH
    Oncotarget; 2017 Aug; 8(33):54331-54344. PubMed ID: 28903345
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic factors and outcomes in metastatic uveal melanoma treated with programmed cell death-1 or combined PD-1/cytotoxic T-lymphocyte antigen-4 inhibition.
    Heppt MV; Heinzerling L; Kähler KC; Forschner A; Kirchberger MC; Loquai C; Meissner M; Meier F; Terheyden P; Schell B; Herbst R; Göppner D; Kiecker F; Rafei-Shamsabadi D; Haferkamp S; Huber MA; Utikal J; Ziemer M; Bumeder I; Pfeiffer C; Schäd SG; Schmid-Tannwald C; Tietze JK; Eigentler TK; Berking C
    Eur J Cancer; 2017 Sep; 82():56-65. PubMed ID: 28648699
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum Levels of MicroRNA miR-371a-3p: A Sensitive and Specific New Biomarker for Germ Cell Tumours.
    Dieckmann KP; Radtke A; Spiekermann M; Balks T; Matthies C; Becker P; Ruf C; Oing C; Oechsle K; Bokemeyer C; Hammel J; Melchior S; Wosniok W; Belge G
    Eur Urol; 2017 Feb; 71(2):213-220. PubMed ID: 27495845
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A comparative analysis of total serum miRNA profiles identifies novel signature that is highly indicative of metastatic melanoma: a pilot study.
    Greenberg E; Besser MJ; Ben-Ami E; Shapira-Frommer R; Itzhaki O; Zikich D; Levy D; Kubi A; Eyal E; Onn A; Cohen Y; Barshack I; Schachter J; Markel G
    Biomarkers; 2013 Sep; 18(6):502-8. PubMed ID: 23902289
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MicroRNA signature associated with treatment response in myasthenia gravis: A further step towards precision medicine.
    Cavalcante P; Mizrachi T; Barzago C; Scandiffio L; Bortone F; Bonanno S; Frangiamore R; Mantegazza R; Bernasconi P; Brenner T; Vaknin-Dembinsky A; Antozzi C
    Pharmacol Res; 2019 Oct; 148():104388. PubMed ID: 31401213
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diagnostic and prognostic roles of circulating miRNA-223-3p in hepatitis B virus-related hepatocellular carcinoma.
    Pratedrat P; Chuaypen N; Nimsamer P; Payungporn S; Pinjaroen N; Sirichindakul B; Tangkijvanich P
    PLoS One; 2020; 15(4):e0232211. PubMed ID: 32330203
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Accurate diagnosis of endometriosis using serum microRNAs.
    Moustafa S; Burn M; Mamillapalli R; Nematian S; Flores V; Taylor HS
    Am J Obstet Gynecol; 2020 Oct; 223(4):557.e1-557.e11. PubMed ID: 32165186
    [TBL] [Abstract][Full Text] [Related]  

  • 32. miR-371a-3p, miR-373-3p and miR-367-3p as Serum Biomarkers in Metastatic Testicular Germ Cell Cancers Before, During and After Chemotherapy.
    Rosas Plaza X; van Agthoven T; Meijer C; van Vugt MATM; de Jong S; Gietema JA; Looijenga LHJ
    Cells; 2019 Oct; 8(10):. PubMed ID: 31597402
    [TBL] [Abstract][Full Text] [Related]  

  • 33. miR-105/93-3p promotes chemoresistance and circulating miR-105/93-3p acts as a diagnostic biomarker for triple negative breast cancer.
    Li HY; Liang JL; Kuo YL; Lee HH; Calkins MJ; Chang HT; Lin FC; Chen YC; Hsu TI; Hsiao M; Ger LP; Lu PJ
    Breast Cancer Res; 2017 Dec; 19(1):133. PubMed ID: 29258605
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association of the peripheral blood levels of circulating microRNAs with both recurrent miscarriage and the outcomes of embryo transfer in an in vitro fertilization process.
    Yang Q; Gu WW; Gu Y; Yan NN; Mao YY; Zhen XX; Wang JM; Yang J; Shi HJ; Zhang X; Wang J
    J Transl Med; 2018 Jul; 16(1):186. PubMed ID: 29973278
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparative study of YKL-40, S-100B and LDH as monitoring tools for Stage IV melanoma.
    Egberts F; Kotthoff EM; Gerdes S; Egberts JH; Weichenthal M; Hauschild A
    Eur J Cancer; 2012 Mar; 48(5):695-702. PubMed ID: 21917447
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Circulating MiR-16-5p and MiR-19b-3p as Two Novel Potential Biomarkers to Indicate Progression of Gastric Cancer.
    Zhang J; Song Y; Zhang C; Zhi X; Fu H; Ma Y; Chen Y; Pan F; Wang K; Ni J; Jin W; He X; Su H; Cui D
    Theranostics; 2015; 5(7):733-45. PubMed ID: 25897338
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MicroRNA expression profiling analysis in serum for nasopharyngeal carcinoma diagnosis.
    Zou X; Zhu D; Zhang H; Zhang S; Zhou X; He X; Zhu J; Zhu W
    Gene; 2020 Feb; 727():144243. PubMed ID: 31743768
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Circulating microRNA-144-3p and miR-762 are novel biomarkers of Graves' disease.
    Yao Q; Wang X; He W; Song Z; Wang B; Zhang J; Qin Q
    Endocrine; 2019 Jul; 65(1):102-109. PubMed ID: 30949910
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association of tumor and plasma microRNA expression with tumor monosomy-3 in patients with uveal melanoma.
    Triozzi PL; Achberger S; Aldrich W; Crabb JW; Saunthararajah Y; Singh AD
    Clin Epigenetics; 2016; 8():80. PubMed ID: 27453764
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Conjunctival malignant melanoma in Denmark: epidemiology, treatment and prognosis with special emphasis on tumorigenesis and genetic profile.
    Larsen AC
    Acta Ophthalmol; 2016 May; 94 Thesis 1():1-27. PubMed ID: 27192168
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.